Entia Liberty: Home Study
Research type
Research Study
Full title
Entia Liberty: Home Study. Evaluation of patient preference for a novel full blood count home testing device versus routine venous monitoring
IRAS ID
317614
Contact name
Sacha Howell
Contact email
Sponsor organisation
Entia
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Research Summary
It is an evaluation of patient preference for our Entia Liberty device (which can monitor full blood count from a finger prick sample) versus standard of care monitoring (full blood count venous blood tests) in cancer patients. The participants enrolled in this study will attend their hospital for registration and enrolment.
They will have a Liberty device, testing consumables, and education material sent to their home directly by Entia and will be trained remotely by a member of staff from Entia via video call on how to use the device. After training, they will use the Liberty device at home on days that they attend the hospital for full blood count monitoring as defined by their hospital’s standard of care for their cancer treatment. The Liberty device will be used in parallel with standard testing so this study will not affect the participants’ care or safety.
After testing twice at home alongside their routine full blood count monitoring, the participant will be issued a questionnaire by Entia to assess their experience and their preference for Entia Liberty versus standard venous monitoring. The participant will then continue to test alongside their standard of care for up to six tests, at which point they will have completed the study. They will be issued a final questionnaire and have their device retrieved from their home.
The results from the surveys will be used to determine the percentage of participants who indicate a preference for Liberty home monitoring versus standard venous monitoring.
Summary of Results
At the end of the study, 59% of participants stated that they prefer using the Entia Liberty blood analyser to having blood tests at a healthcare centre.
REC name
South East Scotland REC 02
REC reference
22/SS/0048
Date of REC Opinion
5 Aug 2022
REC opinion
Further Information Favourable Opinion